Search Within

Matthew David Hellmann

Formats
  1. Meeting Abstract (210)
  2. Journal Article (187)
  3. Review (5)
  4. Editorial (4)
  5. Research Letter (3)
  6. Guidelines (2)
  7. Correspondence (1)
Groups
  1. Department of Medicine (412)
  2. Solid Tumor Oncology Division (412)
  3. Thoracic Oncology (412)
  4. GSK Faculty (140)
  5. Department of Pathology and Laboratory Medicine (112)
  6. Weinberg Fellows (103)

More Groups

People
  1. Hira Rizvi (97)
  2. Mark Kris (71)
  3. Jamie Chaft (68)
  4. Charles Rudin (67)
  5. Jedd Wolchok (53)
  6. Gregory Riely (49)

More People

Years
  1. 2025 (2)
  2. 2024 (7)
  3. 2023 (14)
  4. 2022 (34)
  5. 2021 (40)
  6. 2020 (55)

More Years

Publications
  1. Journal of Clinical Oncology (91)
  2. Journal of Thoracic Oncology (58)
  3. Annals of Oncology (49)
  4. Journal for ImmunoTherapy of Cancer (30)
  5. Cancer Research (24)
  6. Clinical Cancer Research (20)

More Publications

Publishers
  1. American Society of Clinical Oncology (96)
  2. Elsevier Inc. (75)
  3. American Association for Cancer Research (57)
  4. Oxford University Press (53)
  5. Biomed Central Ltd (30)
  6. Nature Publishing Group (21)

More Publishers

Results (412)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Alignment of TMB measured on clinical samples: Phase IIB of the Friends of Cancer Research TMB Harmonization Project
    Meeting Abstract

    Merino, D. M.; Yee, L. M.; McShane, L. M.; Williams, P. M.; Vilimas, T.; Patidar, R.; Barrett, J. C.; Chen, S. J.; Cheng, J. H.; Conroy, J. M.; more...
    Cancer Research (2020)

    Fulltext@MSK | Save
  • A phase Ib study to evaluate RO7198457, an individualized Neoantigen Specific immunoTherapy (iNeST), in combination with atezolizumab in patients with locally advanced or metastatic solid tumors
    Meeting Abstract

    Lopez, J. S.; Camidge, R.; Iafolla, M.; Rottey, S.; Schuler, M.; Hellmann, M.; Balmanoukian, A.; Dirix, L.; Gordon, M.; Sullivan, R.; more...
    Cancer Research (2020)

    Fulltext@MSK | Save
  • Integrative genomic analysis of checkpoint blockade in lung cancer: A multi-institution SU2C collaborative
    Meeting Abstract

    Arniella, M.; Ravi, A.; Stewart, C.; Freeman, S.; Awad, M.; Forde, P.; Anagnostou, V.; Henick, B.; Riess, J.; Gibbons, D.; more...
    Cancer Research (2020)

    Fulltext@MSK | Save
  • Tim-4(+) resident macrophages impair anti-tumor immunity in the serous body cavities by sequestering viable and cytotoxic CD8(+) T cells expressing high levels of phosphatidylserine
    Meeting Abstract

    Chow, A.; Schad, S.; Green, M.; Hellmann, M.; Ceglia, N.; Allaj, V.; Zago, G.; Shah, N.; Sharma, S.; Mattar, M.; more...
    Journal for ImmunoTherapy of Cancer (2020)

    Fulltext@MSK | Save
  • The genomic landscape of SMARCA4 alterations and associations with outcomes in patients with lung cancer
    Journal Article

    Schoenfeld, A.; Bandlamudi, C.; Lavery, J. A.; Montecalvo, J.; Namakydoust, A.; Rizvi, H.; Egger, J.; Concepcion, C. P.; Paul, S.; Arcila, M. E.; more...
    Clinical Cancer Research (2020)

    Fulltext@MSK | Save
  • Survival of responders to nivolumab (NIVO) + ipilimumab (IPI) as first-line treatment for advanced NSCLC in CheckMate 227, part 1
    Meeting Abstract

    Brahmer, J. R.; Ciuleanu, T. E.; Schenker, M.; Audigier-Valette, C.; Zurawski, B.; Linardou, H.; Kim, S. W.; Otterson, G. A.; Salman, P.; De La Mora Jimenez, E.; more...
    Annals of Oncology (2020)

    Fulltext@MSK | Save
  • Prognostic and predictive impact of circulating tumor DNA in patients with advanced cancers treated with immune checkpoint blockade
    Journal Article

    Zhang, Q.; Luo, J.; Wu, S.; Si, H.; Gao, C.; Xu, W.; Abdullah, S. E.; Higgs, B. W.; Dennis, P. A.; van der Heijden, M. S.; more...
    Cancer Discovery (2020)

    Fulltext@MSK | Save
  • Safety of thoracic radiotherapy in patients with prior immune-related adverse events from immune checkpoint inhibitors
    Journal Article

    Shaverdian, N.; Beattie, J.; Thor, M.; Offin, M.; Shepherd, A. F.; Gelblum, D. Y.; Wu, A. J.; Simone, C. B. 2nd; Hellmann, M. D.; Chaft, J. E.; more...
    Annals of Oncology (2020)

    Fulltext@MSK | Save
  • One-year disease outcomes in stage III non-small cell lung cancers treated with trimodality therapy vs concurrent chemoradiation and durvalumab
    Meeting Abstract

    Shaverdian, N.; Shepherd, A. F.; Offin, M.; Lobaugh, S.; Zhang, Z.; Simone, C. B. 2nd; Gelblum, D.; Wu, A. J.; Kris, M. G.; Rudin, C. M.; more...
    International Journal of Radiation Oncology, Biology, Physics (2020)

    Fulltext@MSK | Save
  • Inter-tumoral heterogeneity of progressive disease in melanoma patients treated with pembrolizumab
    Meeting Abstract

    Topp, B.; Kumar, R.; Mayawala, K.; de Alwis, D.; Hellmann, M. D.; Snyder, A.
    Cancer Research (2020)

    Fulltext@MSK | Save